REFERENCES
  1. Streng A, Wiegering V, Liese JG. Varicella in pediatric oncology patients in the post-vaccine era-Analysis of routine hospital data from Bavaria (Germany), 2005-2011. Pediatr Hematol Oncol. 2016 Oct-Nov;33(7-8):468-479.
  2. Düzgöl M, Özek G, Bayram N, Oymak Y, Kara A, Demirağ B, Karapınar TH, Ay Y, Vergin C, Devrim İ. Varicella-Zoster Virus Infections in Pediatric Malignancy Patients: A Seven-Year Analysis. Turk J Haematol. 2016 Dec 1;33(4):346-348.
  3. Meyers J, Logaraj M, Ramraj B, Narasimhan P, MacIntyre CR. Epidemic Varicella Zoster Virus among University Students, India. Emerg Infect Dis. 2018 Feb;24(2):366-369.
  4. Sung L, Heurter H, Zokvic KM, Ford-Jones EL, Weitzman SS, Freeman R, Dupuis LL, Scheifele DW. Practical vaccination guidelines for children with cancer. Paediatr Child Health. 2001 Jul;6(6):379-83.
  5. Lachiewicz AM, Srinivas ML. Varicella-zoster virus post-exposure management and prophylaxis: A review. Prev Med Rep. 2019 Nov 6;16:101016. doi: 10.1016/j.pmedr.2019.101016. Erratum in: Prev Med Rep. 2020 Dec 13;20:101283.
  6. Koka A, Saygin C, Uzunaslan D, Ozdemir N, Apak H, Celkan T. A 17-year experience with ALL-BFM protocol in acute lymphoblastic leukemia: prognostic predictors and interruptions during protocol. Leuk Res. 2014 Jun;38(6):699-705.
  7. Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer. 2007 Dec;49(7):941-6.
  8. Oberoi S, Trehan A, Marwaha RK, Bansal D. Symptom to door interval in febrile neutropenia: Support Care Cancer. 2013 May;21(5):1321-7.